EcoDrugPlus

Integrin Alpha-V-Like

Ensembl ID : ENSCVAG00000007779
Gene Symbol: LOC107098331
3 Cross references
238 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSCVAG00000015399
Gene Symbol: LOC107094308
3 Cross references
209 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSCVAG00000012166
Gene Symbol: LOC107084752
3 Cross references
204 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCVAG00000006959
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSCVAG00000013623
Gene Symbol: ITGB1
3 Cross references
230 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSCVAG00000021214
Gene Symbol: ITGB3
3 Cross references
195 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSCVAG00000014717
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSCVAG00000014278
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSCVAG00000004993
Gene Symbol: ITGB5
1 Cross references
211 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSCVAG00000000870
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4-Like

Ensembl ID : ENSCVAG00000006548
Gene Symbol: LOC107103744
2 Cross references
189 Possible Orthologues:

Interstitial Collagenase-Like

Ensembl ID : ENSCVAG00000019610
Gene Symbol: LOC107083460
2 Cross references
164 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).